Hims & Hers Shares Surge as Novo Nordisk Drops Patent Lawsuit
Hims & Hers Health posted a wider-than-expected second-quarter loss as the telehealth company transitioned its model toward branded weight-loss drugs, following a strategic pivot that included dropping legal battles with … Read More